InvestorsHub Logo
Followers 164
Posts 3102
Boards Moderated 0
Alias Born 11/03/2014

Re: eagle8 post# 589643

Sunday, 04/30/2023 9:21:37 AM

Sunday, April 30, 2023 9:21:37 AM

Post# of 704237
Yes eagle8, that’s exactly what this clinical trial is looking at: whether Pembrolizumab added to the control of ATL-DC (DCVax-L) + poly-ICLC, adds any additional overall survival, compared to ATL-DC + poly-ICLC alone.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News